Improved biological activity of antisense oligonucleotides conjugated to a fusogenic peptide.
about
Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptidesDiels-Alder cycloadditions in water for the straightforward preparation of peptide-oligonucleotide conjugatesPeptide antisense nanoparticles.The spherulites(TM): a promising carrier for oligonucleotide delivery.New phosphoramidite reagents for the synthesis of oligonucleotides containing a cysteine residue useful in peptide conjugation.Cellular uptake of antisense oligonucleotides after complexing or conjugation with cell-penetrating model peptides.Peptide conjugates for chromosomal gene targeting by triplex-forming oligonucleotidesGenetically engineered polymers for drug delivery.Oligonucleotides tethered to a short polyguanylic acid stretch are targeted to macrophages: enhanced antiviral activity of a vesicular stomatitis virus-specific antisense oligonucleotideUse of 1,2,4-dithiazolidine-3,5-dione (DtsNH) and 3-ethoxy-1,2,4-dithiazoline-5-one (EDITH) for synthesis of phosphorothioate-containing oligodeoxyribonucleotides.Characterization of peptide-oligonucleotide heteroconjugates by mass spectrometry.Construction and characterization of novel, completely human serine protease therapeutics targeting Her2/neuTargeted gene modification of hematopoietic progenitor cells in mice following systemic administration of a PNA-peptide conjugateBioconjugation of oligonucleotides for treating liver fibrosis.Facilitating oligonucleotide delivery: helping antisense deliver on its promise.Smart drug delivery nanocarriers with self-assembled DNA nanostructures.Targeted delivery of miRNA therapeutics for cardiovascular diseases: opportunities and challenges.Exploiting protected maleimides to modify oligonucleotides, peptides and peptide nucleic acids.Histidylated oligolysines increase the transmembrane passage and the biological activity of antisense oligonucleotidesPhosphorothioate oligodeoxyribonucleotides dissociate from cationic lipids before entering the nucleus.A new approach to the synthesis of the 5'-deoxy-5'-methylphosphonate linked thymidine oligonucleotide analogues.Cell cycle dependent toxicity of an amphiphilic synthetic peptide.Role of endosomes in gene transfection mediated by photochemical internalisation (PCI).Gene therapy: Recent advances and applications in gastroenterology and hepatology.Delivery of oligonucleotides into mammalian cells by anionic peptides: comparison between monomeric and dimeric peptides.Peptide-mediated Cell and In Vivo Delivery of Antisense Oligonucleotides and siRNA.Synthesis of peptide-oligonucleotide phosphorothioate conjugates by convergent or stepwise solid-phase strategies.A new "native ligation" procedure for peptide-oligonucleotide conjugation.The solution synthesis of antisense oligonucleotide-peptide conjugates directly linked via phosphoramide bond by using a fragment coupling approach.Specific 3'-terminal modification of DNA with a novel nucleoside analogue that allows a covalent linkage of a nuclear localization signal and enhancement of DNA stability.Mechanism of the sulfurisation of phosphines and phosphites using 3-amino-1,2,4-dithiazole-5-thione (xanthane hydride).Concise Synthesis of Triazole-Linked 5'-Peptide-Oligonucleotide Conjugates by Click Chemistry.
P2860
Q24793327-8BA64BC1-5CF5-4783-92BB-695AFF147D38Q25255749-B1C0B41E-BF9D-4EBD-9FFE-90FC0AEBCC70Q30484525-10CFC15C-2D45-4D41-86AF-7FBD2FE659E5Q30897989-07AE6DA5-5AC1-425A-98AD-B04BEB320E4DQ30980242-C88D6F57-4C78-4FF2-84B7-28C381ED64E1Q31104360-DE449215-CA53-48F3-9310-335D7253D4AEQ33754501-DFB74611-455B-4983-BA2E-22D11BF432B3Q33805942-E8260529-5B4B-42B4-83ED-31F29142139AQ33978043-77050F18-1CCB-40AB-A831-447D4C795973Q34595650-75C03732-EAFF-4F85-93EC-A7DDA16E2907Q34612676-C7595688-E530-4EDA-8966-3ACC686D6A4FQ35541200-0D936F6F-0821-4DE3-AA02-1EA6C480877FQ35665225-3C6418E7-6E00-4960-8684-9451FD0A0CB8Q37043515-A223DF62-8BEF-4DE2-B5B2-1F3CB6F096CFQ37642947-D1F44F92-0A03-411F-815D-5604D5AE99DCQ38114373-FF98ED0A-6155-43F2-BF6D-770EF804FE55Q38217461-41B24CAE-6DCA-44F4-8DFF-4F32C8C7D6F0Q38418294-2993E3DD-3845-4171-ADEF-F7EFF9C0B2F9Q39541959-8D337383-EEAE-4EB7-9FF4-9F8D668DA5BFQ39723515-EA805592-7F1D-4484-AB02-A158C6260A31Q40393378-42332B0B-0736-4592-BCAC-F5C33FBAF732Q41074233-E7317264-72C2-4AB9-85AF-FA1A825D9767Q41920317-29898725-BBB9-4023-93C5-CE1CE1ABD84BQ41924509-CF765A9C-FA9F-4C46-9066-7075CECE2AC0Q42010311-14DAEC0E-92B8-465B-9DBB-ADFA5C96D5CAQ42226373-1F6156DE-C0D3-42DB-A522-DEB6E1A9DF10Q43741871-FB7CF11D-CC4A-4B0E-B9A1-19B0E63360B4Q43741969-849799BD-742A-4533-8D51-00708E47B65BQ45208898-A619FAC3-61CB-4235-80B7-5AA491A79F4CQ45242811-0ACA0E13-5C2F-47D5-9FD4-F12DD0A02165Q52676203-E70815C0-D260-4A6E-8070-12249EC12FF2Q53184646-E2239D2D-751E-46CE-92EF-4C7333A1F580
P2860
Improved biological activity of antisense oligonucleotides conjugated to a fusogenic peptide.
description
1994 nî lūn-bûn
@nan
1994 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Improved biological activity o ...... ugated to a fusogenic peptide.
@ast
Improved biological activity o ...... ugated to a fusogenic peptide.
@en
Improved biological activity o ...... ugated to a fusogenic peptide.
@nl
type
label
Improved biological activity o ...... ugated to a fusogenic peptide.
@ast
Improved biological activity o ...... ugated to a fusogenic peptide.
@en
Improved biological activity o ...... ugated to a fusogenic peptide.
@nl
prefLabel
Improved biological activity o ...... ugated to a fusogenic peptide.
@ast
Improved biological activity o ...... ugated to a fusogenic peptide.
@en
Improved biological activity o ...... ugated to a fusogenic peptide.
@nl
P2093
P2860
P356
P1476
Improved biological activity o ...... ugated to a fusogenic peptide.
@en
P2093
Aubertin AM
Bongartz JP
Milhaud PG
P2860
P304
P356
10.1093/NAR/22.22.4681
P407
P577
1994-11-01T00:00:00Z